CONVERTIBLECAR
Live / Registered — Registered (as of 10 Mar 2026)
What this means for you
Registered since 10 Mar 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Mar 2032: the §8 declaration of use).
Record
- Serial number
- 98280616
- Registration number
- 8170336
- Mark type
- Word mark
- Filed
- 21 Nov 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 10 Mar 2026
- Next maintenance filing
- §8 declaration of use, due by 10 Mar 2032 (grace period to 10 Sept 2032)
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of biologic agents for adoptive cellular therapy
Owner
- Xyphos Biosciences, Inc., South San Francisco, CA, US
- Xyphos Biosciences, Inc., South San Francisco, CA, US
- Xyphos Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Oct 2025 — NON-FINAL ACTION E-MAILED
- 18 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 03 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2025 — USE AMENDMENT FILED
- 02 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED